FAITH SHINN: Open Payments
NPI 1023516614 · DALLAS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 28 payments from 14 companies in 2025. Trend: 2023 $21 · 2024 $24 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $145 |
| Amgen Inc. | 4 | $91 |
| Exact Sciences Corporation | 3 | $66 |
| PFIZER INC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: EVENITY, The Cologuard Plus Collection Kit, Ozempic, PREVNAR 20, REXULTI, UBRELVY, SHINGRIX, SLYND.
Industry payments across OR — which companies pay providers there.
